The molecular pathogenesis of Clostridium difficile-associated disease

Current Infectious Disease Reports

Volumn 10, Issue 2, 2008, Pages 111-115

  Bobak, David A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CLOSTRIDIUM DIFFICILE TOXIN C; CLOSTRIDIUM TOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; APOPTOSIS; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; GLYCOSYLATION; HUMAN; INTESTINE MUCOSA; LEUKOCYTE ACTIVATION; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TRANSPOSON;

EID: 56349165668     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-008-0020-0     Document Type: Review

References (43)

1. Bartlett JG: Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006, 145:758-764.
2. Blossom DB, McDonald LC: The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007, 45:222-227.
3. Cloud J, Kelly CP: Update on Clostridium difficile associated disease. Curr Opin Gastroenterol 2007, 23:4-9.
4. McMaster-Baxter NL, Musher DM: Clostridium difficile: recent epidemiologic findings and advances in therapy. Pharmacotherapy 2007, 27:1029-1039.
5. Voth DE, Ballard JD: Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005, 18:247-263.
6. Jank T, Giesemann T, Aktories K: Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 2007, 17:15R-22R.
7. Cohen SH, Tang YJ, Silva J Jr: Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis 2000, 181:659-663.
8. Spigaglia P, Mastrantonio P: Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002, 40:3470-3475.
9. McDonald LC, Killgore GE, Thompson A, et al.: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433-2441.
10. Curry SR, Marsh JW, Muto CA, et al.: tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 2007, 45:215-221.
11. Stabler RA, Gerding DN, Songer JG, et al.: Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 2006, 188:7297-7305.
12. Sebaihia M, Wren BW, Mullany P, et al.: The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 2006, 38:779-786.
13. Carter GP, Purdy D, Williams P, Minton NP: Quorum sensing in Clostridium difficile: analysis of a luxS-type signalling system. J Med Microbiol 2005, 54:1119-1127.
14. Cookson B: Hypervirulent strains of Clostridium difficile. Postgrad Med J 2007, 83:291-295.
15. Drudy D, Fanning S, Kyne L: Toxin A-negative, toxin B-positive Clostridium difficile. Int J Infect Dis 2007, 11:5-10.
16. Matamouros S, England P, Dupuy B: Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 2007, 64:1274-1288.
17. Heap JT, Pennington OJ, Cartman ST, et al.: The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods 2007, 70:452-464.
18. Ho JG, Greco A, Rupnik M, Ng KK: Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc Natl Acad Sci U S A 2005, 102:18373-18378.
19. Greco A, Ho JG, Lin SJ, et al.: Carbohydrate recognition by Clostridium difficile toxin A. Nat Struct Mol Biol 2006, 13:460-461.
20. Stubbe H, Berdoz J, Kraehenbuhl JP, Corthésy B: Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol 2000, 164:1952-1960.
21. Giesemann T, Jank T, Gerhard R, et al.: Cholesterol-dependent pore formation of Clostridium difficile toxin A. J Biol Chem 2006, 281:10808-10815.
22. Pfeifer G, Schirmer J, Leemhuis J, et al.: Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J Biol Chem 2003, 278:44535-44541.
23. Rupnik M, Pabst S, Rupnik M, et al.: Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 2005, 151:199-208.
24. Reineke J, Tenzer S, Rupnik M, et al.: Autocatalytic cleavage of Clostridium difficile toxin B. Nature 2007, 446:415-419.
25. Egerer M, Giesemann T, Jank T, et al.: Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J Biol Chem 2007, 282:25314-25321.
26. Jaffe AB, Hall A: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005, 21:247-269.
27. Bustelo XR, Sauzeau V, Berenjeno IM: GTP-binding proteins of the Rho/ Rac family: regulation, effectors and functions in vivo. Bioessays 2007, 29:356-370.
28. Reinert DJ, Jank T, Aktories K, Schulz GE: Structural basis for the function of Clostridium difficile toxin B. J Mol Biol 2005, 351:973-981.
29. Jank T, Reinert DJ, Giesemann T, et al.: Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis. J Biol Chem 2005, 280:37833-37838.
30. Jank T, Pack U, Giesemann T, et al.: Exchange of a single amino acid switches the substrate properties of RhoA and RhoD toward glucosylating and transglutaminating toxins. J Biol Chem 2006, 281:19527-19535.
31. Jank T, Giesemann T, Aktories K: Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding. J Biol Chem 2007, 282:35222-35231.
32. Barth H, Aktories K, Popoff MR, Stiles BG: Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 2004, 68:373-402.
33. Geric B, Carman RJ, Rupnik M, et al.: Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 2006, 193:1143-1145.
34. Matarrese P, Falzano L, Fabbri A, et al.: Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels. J Biol Chem 2007, 282:9029-9041.
35. Huelsenbeck J, Dreger S, Gerhard R, et al.: Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470. Infect Immun 2007, 75:801-809.
36. Chaves-Olarte E, Freer E, Parra A, et al.: R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile. J Biol Chem 2003, 278:7956-7963.
37. Gerhard R, Tatge H, Genth H, et al.: Clostridium difficile toxin A induces expression of the stress-induced early gene product RhoB. J Biol Chem 2005, 280:1499-1505.
38. Chae S, Eckmann L, Miyamoto Y, et al.: Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury. J Immunol 2006, 177:1214-1220.
39. Huelsenbeck J, Dreger SC, Gerhard R, et al.: Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile. Biochemistry 2007, 46:4923-4931.
40. Kim H, Rhee SH, Kokkotou E, et al.: Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J Biol Chem 2005, 280:21237-21245.
41. Lee JY, Park HR, Oh YK, et al.: Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A. J Mol Med 2007, 85:1393-1404.
42. Anton PM, Gay J, Mykoniatis A, et al.: Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci U S A 2004, 101:8503-8508.
43. Tait AS, Dalton M, Geny B, et al.: The large clostridial toxins from Clostridium sordellii and C. difficile repress glucocorticoid receptor activity. Infect Immun 2007, 75:3935-3940.